Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Acute disseminated encephalomyelitis laboratory findings
Introduction
Overview
Overview
Antibodies like anti-MOG antibodies are found in the serum of patients suffering from ADEM. A lumbar puncture is also useful for evaluation of the changes in the Cerebrospinal fluid (CSF).
Laboratory Findings
Laboratory Findings
Antibodies
- High titers of anti-MOG antibodies are found in the acute phase, which tends to decrease and eventually disappear over time[1][2].
- IgG autoantibodies targeting myelin autoantigens such as MBP, alpha-B crystalline and PLP may help distinguish ADEM from MS[3].
- Presence of serum anti-AQP4-IgG antibodies rules out a diagnosis of ADEM.
CSF studies
- Non-specific lymphocytic pleocytosis and elevated albumin levels[4]
- Transient [5] oligoclonal banding with a median frequency of 12.5% (range 0-29%)[6] in children and higher in the adult cases (37.5-58%)[5].
- Identification of the pathogen by specific cell-culture techniques or PCR[7][8]. The high prevalence of neurtropic viruses in the general population may lead to a spurious PCR result, making it difficult to prove a causal relation.
References
References
- ↑ Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S; et al. (2015). “Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein”. J Neurol Neurosurg Psychiatry. 86 (3): 265–72. doi:10.1136/jnnp-2014-308346. PMID 25121570.
- ↑ Di Pauli F, Mader S, Rostasy K, Schanda K, Bajer-Kornek B, Ehling R; et al. (2011). “Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases”. Clin Immunol. 138 (3): 247–54. doi:10.1016/j.clim.2010.11.013. PMID 21169067.
- ↑ Van Haren K, Tomooka BH, Kidd BA, Banwell B, Bar-Or A, Chitnis T; et al. (2013). “Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis”. Mult Scler. 19 (13): 1726–33. doi:10.1177/1352458513485653. PMC 4411183. PMID 23612879.
- ↑ Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B (2001). “Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients”. Neurology. 56 (10): 1313–8. doi:10.1212/wnl.56.10.1313. PMID 11376180.
- ↑ 5.0 5.1 O’Riordan JI, Gomez-Anson B, Moseley IF, Miller DH (1999). “Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease”. J Neurol Sci. 167 (2): 132–6. doi:10.1016/s0022-510x(99)00160-4. PMID 10521553.
- ↑ Gupte G, Stonehouse M, Wassmer E, Coad NA, Whitehouse WP (2003). “Acute disseminated encephalomyelitis: a review of 18 cases in childhood”. J Paediatr Child Health. 39 (5): 336–42. doi:10.1046/j.1440-1754.2003.00154.x. PMID 12887662.
- ↑ Fujimoto H, Asaoka K, Imaizumi T, Ayabe M, Shoji H, Kaji M (2003). “Epstein-Barr virus infections of the central nervous system”. Intern Med. 42 (1): 33–40. doi:10.2169/internalmedicine.42.33. PMID 12583615.
- ↑ Riedel K, Kempf VA, Bechtold A, Klimmer M (2001). “Acute disseminated encephalomyelitis (ADEM) due to Mycoplasma pneumoniae infection in an adolescent”. Infection. 29 (4): 240–2. doi:10.1007/s15010-001-1173-z. PMID 11545490.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]